ArticleApplied biochemistry and biotechnology2023
Molecularly Imprinted Cryogels for the Selective Adsorption of Salicylic Acid.
Article in Applied biochemistry and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In this study, molecularly imprinted cryogels were fabricated for selective adsorption of salicylic acid. Cryogelation was performed at - 20 °C using a cationic monomer N,N-dimethylaminoethyl methacrylate as a functional monomer for salicylic acid. The morphology, swelling behaviors, and chemical structures of the cryogels were investigated. The general structure and porosities of cryogels were compared with the traditional hydrogels using field emission scanning electron microscopy (FE-SEM). The adsorption performance of cryogels toward salicylic acid was studied to investigate the optimal adsorption conditions. Adsorption capacity of the imprinted cryogels was 1.95 and 7.51 times higher than those of non-imprinted and bare PHEMA cryogels, respectively, due to the specific binding sites toward salicylic acid. Molecularly imprinted cryogels exhibited significant stability and reusability by keeping more than 85% of their adsorption capacity after ten regeneration cycles. Considering the fabrication process, adsorption capacity, selectivity, and reusability of the imprinted cryogels, these new materials could be utilized as a promising alternative for selective adsorption of drug molecules.
Indexed as
Identifiers
36399302What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.